Tesseract Medicines
Latest round
- Seed
Last raised
- Jun 2024
Total raised
- $20M
Investors
- 3
About Tesseract Medicines
Founded in 2022 and based in Massachusetts, US, Tesseract Medicines provides biopharmaceutical drugs for treating cancer. The company sells antibody-drug conjugates, which are biopharmaceutical medications used to treat cancer. It is designed to benefit from intracellular proteins specific to cancer and anti-drug conjugates, which are biopharmaceutical drugs used in cancer treatment. The company offers novel therapeutics that help in exploiting cancer–specific intracellular proteins.
Who invested in Tesseract Medicines
3 investors across 1 round
See all investors in Tesseract Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 10, 2024
Amount
$20M
Investors
Questions about Tesseract Medicines
Who invested in Tesseract Medicines?
Tesseract Medicines has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tesseract Medicines raised?
Tesseract Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tesseract Medicines last raise money?
Tesseract Medicines's most recent round on record is a Seed, in Jun 2024.
What does Tesseract Medicines do?
Founded in 2022 and based in Massachusetts, US, Tesseract Medicines provides biopharmaceutical drugs for treating cancer.
Where is Tesseract Medicines headquartered?
Tesseract Medicines is headquartered in Newton, US.
Which VCs invest in companies like Tesseract Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tesseract Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Tesseract Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.